[28P1-am2-079S] An aspartic protease secreted by the fungus Malassezia inhibits Staphylococcus aureus biofilm formation

○Sora Matsumura¹, Otomi Cho¹, Reina Azuma¹, Miho Takeda¹, Tamao Kobayashi¹, Erika Mori¹, Yasuhiko Matsumoto¹, Takashi Sugita¹ (1. Meiji Pharm Univ.)

[28P1-am2-080S] Lipase secreted by skin commensal fungus, Malassezia globosa is involved in the development of dermatitis: analysis using a 3D cultured epidermal model

○Miho Takeda¹, Otomi Cho¹, Yasuhiko Matsumoto¹, Takashi Sugita¹ (1. Meiji pharm Univ.)

[28P1-am2-081S] The Slt2-MAPK pathway is involved in cell wall integrity (CWI) of the skin fungus Malassezia furfur

○Tamao Kobayashi¹, Otomi Cho¹, Reina Azuma¹, Miho Takeda¹, Yasuhiko Matsumoto¹, Takashi Sugita¹ (1. Meiji Pharm Univ.)

[28P1-am2-082S] The skin fungus Malassezia globosa adapts to environmental stress via the Hog1 MAPK pathway

○Erika Mori¹, Otomi Cho¹, Reina Azuma¹, Miho Takeda¹, Tamao Kobayashi¹, Sora Matsumura¹, Yasuhiko Matsumoto¹, Takashi Sugita¹ (1. Meiji Pharm Univ.)

[28P1-am2-083S] Elucidation of innate immune inducing systems in silkworms by Staphylococcus aureus and Cutibacterium acnes, which are involved in inflammation related skin diseases.

○Eri Sato¹, Yasuhiko Matsumoto¹, Takashi Sugita¹ (1. Meiji Pharm Univ.)

[28P1-am2-084S] The effect of metal cation on tolerance to antimicrobial agent in biofilms by blood-derived Escherichia coli

○Yurie Ikura¹, Sanae Kurakado¹, Shintarou Eshima^1,2, Yasuhiko Matsumoto¹, Takayuki Kudou³, Takashi Sugita¹ (1. Meiji Pharm Univ., 2. PP, Toshiba Rinkan HP., 3. ML, Toshiba Rinkan HP.)

[28P1-am2-085S] Regulation of a MAP kinase Hog1 in stress responses and virulence of the pathogenic fungus Trichosporon asahii

○Yu Sugiyama¹, Yasuhiko Matsumoto¹, Tae Nagamachi¹, Asami Yoshikawa¹, Takashi Sugita¹ (1. Meiji Pharm Univ.)

[28P1-am2-086S] Gpa1, a GTP binding protein, contributes to biofilm formation in the pathogenic fungus Trichosporon asahii

○Sachi Koganesawa¹, Yasuhiko Matsumoto¹, Hiromi Kanai¹, Takashi Sugita¹ (1. Meiji Pharm Univ.)

[28P1-am2-087S] Involvement of the Plc1-signaling pathway in the growth of the pathogenic fungus Trichosporon asahii

○Hiromi Kanai¹, Yasuhiko Matsumoto¹, Sachi Koganesawa¹, Takashi Sugita¹ (1. Meiji Pharm Univ.)

[28P1-am2-088S] Involvement of Crz1 on stress tolerance in pathogenic fungus Trichosporon asahii

○Yuta Shimizu¹, Yasuhiko Matsumoto¹, Katsura Yoshitomo¹, Jureki Endo¹, Takashi Sugita¹ (1. Meiji Pharm Univ.)

[28P1-am2-089S] Roles of atg1, an autophagy-related gene, on the growth of pathogenic fungus Trichosporon asahii under a nitrogen-starved condition

○Mei Nakayama¹, Yasuhiko Matsumoto¹, Ayumi Yonemoto¹, Kazumu Miyamoto¹, Sanae Kurakado¹, Takashi Sugita¹ (1. Meiji Pharm Univ.)

[28P1-am2-090S] Requirement of a MAP kinase Mpk1 on cell membrane and cell wall maintenances in pathogenic fungus Trichospocon asahii

○Katsura Yoshitomo¹, Yasuhiko Matsumoto¹, Jureki Endo¹, Yuta Shimizu¹, Takashi Sugita¹ (1. Meiji Pharm Univ.)

[28P1-am2-091] FK506 inhibits hyphal formation through the calcineurin signaling pathway in pathogenic fungus Trichosporon asahii

○Sanae Kurakado¹, Yasuhiko Matsumoto¹, Tsuyoshi Yamada^2,3, Kiminori Shimizu^4,5, Shogo Wakasa¹, Takashi Sugita¹ (1. Meiji Pharm. Univ., 2. TIMM, Teikyo Univ., 3. ADC, Teikyo Univ., 4. BST, Tokyo Univ. of Sci., 5. MMRC, Chiba Univ.)

[28P1-am2-092] Role of proton pumping ATPase in acid tolerance mechanism of Streptococcus mutans

○mizuki sekiya¹, kazuya ikeda¹, ayaka yonai¹, yu shimoyama², taichi ishikawa², yoshitoyo kodama², minoru sasaki², mayumi nakanishi-matsui¹ (1. Sch. Pharm., Iwate Med. Univ., 2. Sch. Dent., Iwate Med. Univ.)

[28P1-am2-093S] Experimental Streptococcus pneumoniae infection model using a 3D human organotypic lung tissue model system

○Emi Tanaka^1,2, Takeaki Wajima², Hidemasa Nakaminami¹, Kei-ichi Uchiya² (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci. , 2. Fac. Pharm., Meijo Univ. )

[28P1-am2-094S] The analysis of cytotoxicity-inducing domain of RtxA1 toxin produced by Vibrio vulnificus

○Hina Sugimura¹, Kyoka Kaji¹, Mayu Suda¹, Takahiro Tsuchiya¹, Katsushiro Miyamoto¹, Jun Komano¹, Hiroshi Tsujibo¹ (1. Faculty Pharm. Osaka Med. Pharm, Univ.)

[28P1-am2-095S] Regulation of type III secretion system by cAMP receptor protein in Vibrio parahaemolyticus

○Mitsuki Tsukamoto¹, Tomotaka Tanabe¹, Mahiro Shioda¹, Kenjiro Nagaoka¹, Tatsuya Funahashi¹ (1. Col. Pharm. Sci., Matsuyama Univ.)

[28P1-am2-096S] Aeromonas serine protease decreases epithelial barrier function and promotes bacterial translocation

○Haruki Fukuda¹, Hidetomo Kobayashi¹, Soshi seike¹, Eizo Takahashi², Keinosuke Okamoto³, Hiroyasu Yamanaka¹ (1. Labo. Mol. Microbiol. Sci., Fac. Pharm. Sci., Hiroshima Int. Uni., 2. Labo. Med. Microbiol., Dept. health pharm., Yokohama Univ. Pharm., 3. Okayama Univ. Grad. Sch. of Med., Dent. and Pharm.. Sci)

[28P1-am2-097S] Analysis of glycolipid recognition mechanism in intestinal tissue invasion of Aeromonas

○Kaiki Mori¹, Hidetomo Kobayashi¹, Soshi Seike¹, Eizo Takahash², Keinosuke Okamoto³, Hiroyasu Yamanaka¹ (1. Labo. Mol. Microbiol. Sci., Fac. Pharm. Sci., Hiroshima Int. Univ., 2. Labo. Med. Microbiol., Dept. health pharm., Yokohama Univ. Pharm., 3. Okayama Univ. Grad. Sch. of Med., Dent. and Pharm. Sci.)

[28P1-am2-098S] The analysis of cytotoxity by bOMVs released from Aeromonas formed biofilm

○yuya shimabuku¹, soushi seike¹, hidetomo kobayashi¹, eizou takahashi², keinosuke okamoto³, hiroyasu yamanaka¹ (1. Labo. Mol. Microbiol. Sci., Fac. Pharm. Sci., Hiroshima Int. Univ., 2. Labo. Med. Microbiol., Dept. health pharm., Yokohama Univ. Pharm., 3. Okayama Univ. Grad. Sch. of Med., Dent. and Pharm. Sci.)

[28P1-am2-099] Isolation and characterization of a substrain of hepatitis C virus capable of infecting iPS cells

○Tomoharu Mizukami¹, Yoshitaka Shirasago¹, Hidesuke Fukazawa¹, Shotaro Nagase², Yoshimi Shimizu^1,3, Takaji Wakita¹, Tetsuro Suzuki⁴, Hideki Tani⁵, Masuo Kondoh², Takuya Kuroda⁶, Satoshi Yasuda⁶, Yoji Sato⁶, Kentaro Hanada¹, Masayoshi Fukasawa¹ (1. NIID, 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. Dept. Pharm. Sci., Teikyo Heisei Univ., 4. Hamamatsu Univ. Sch. Med., 5. Toyama Inst. Health, 6. NIHS)

Session information

[28P1-am2] Pathogenesis and infection